• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

GCC-Exclusive Skincare Formula vs Exclusive Packaging: What Should the Brand Agreement Separate?

Two different assets get bundled into one clause in most GCC skincare agreements: an exclusive formula and exclusive packaging. They behave nothing alike commercially, regulatorily, or operationally — and treating them as one line…

Category: Skincare Sourcing Guides • Author: laeyo • Published: 2026-11-12 • Views: 30

Two different assets get bundled into one clause in most GCC skincare agreements: an exclusive formula and exclusive packaging. They behave nothing alike commercially, regulatorily, or operationally — and treating them as one line item is one of the most common reasons a Gulf launch slips a quarter or ends in a renegotiation. A formula carries registration consequences in each country where you file, lives inside a versioned specification, and is only defensible if the tested sample matches the commercial batch. Packaging carries tooling ownership, decoration plates, a validated combination ID, and a climate-and-transit engineering problem that has nothing to do with the formula’s exclusivity. This guide sets out how to separate the two in the brand agreement so that sourcing, regulatory filing, and quality each get a clean scope to work against. Informational only, not legal advice.

Why the Two Exclusive Assets Need Separate Clauses

Exclusivity is only useful if it is enforceable and operationally real. A formula exclusive to your brand but filled into a stock bottle sold to three competitors is a half-exclusive product. A custom mould exclusive to your brand but paired with a formula your manufacturer may supply to anyone is equally weak. The agreement has to state, separately, what is owned, what is licensed, who may use it, in which countries, for how long, and against what volume.

  • Formula exclusivity is a documentation and change-control commitment. It is proven by a Formula ID, a frozen version, a controlled specification, and a dossier you can file in each target country.
  • Packaging exclusivity is a tooling and validation commitment. It is proven by a Combination ID, supplier part numbers, decoration approvals, a Golden Packaging sample, and compatibility/leak/transport records.
  • Registration attaches to the product as filed, not to the marketing story. In the UAE, Dubai registration through the Montaji consumer product system does not travel automatically to the other emirates or to Saudi Arabia, and it does not cover the GCC as a block.
  • Claims attach to the tested sample. If the fragrance, preservative, key actives, or process change between the efficacy test and the commercial batch, an impact assessment is required — the claim cannot quietly ride on the old data.

Formula Exclusivity vs Packaging Exclusivity: Side-by-Side

Dimension Exclusive formula Exclusive packaging
What is actually owned Formula ID and frozen version; the developed know-how as defined in the contract; the technical dossier Tooling/mould, decoration artwork and plates, supplier part numbers within a Combination ID
Main cost driver Development, stability and compatibility testing, efficacy and consumer studies, dossier preparation Mould amortisation, decoration tooling, MOQ per component, Golden Packaging samples
Typical lead time Longer if efficacy or consumer claims are involved; stability and micro run in parallel with filling trials Longer if new mould or new decoration is required; stock components still need validation against your formula
Market dependency Must be defined per country: Saudi notification versus UAE (Dubai Municipality / Montaji) versus other GCC states Defined by physical conditions: high heat, humidity, transit, retail storage, gifting/coffret packing
Impact of a change May trigger re-testing, label changes, and re-filing in each market May trigger re-validation of seal, dose, spray, and transport performance
Reference document Approved Specification: identity, physical/chemical, micro, functional, net content, method IDs, acceptance criteria, change control Combination ID record: bottle, pump/sprayer, cap/collar, gasket/dip tube, decoration, formula ID, validation index, Golden Packaging
How exclusivity is usually priced Development fee plus volume-based or term-based exclusivity Tooling fee plus minimum order quantity per component or per SKU
Failure mode if bundled Exclusivity lapses silently when the formula is revised without notice Exclusivity is claimed over a component the factory did not actually reserve

What “GCC-Exclusive” Must Mean in Writing

Name the countries, not the region

The Gulf is not one market. Regulatory route, import process, channel structure, price architecture, and consumer usage all differ — Saudi Arabia and the UAE are the clearest example. A clause that grants exclusivity for “GCC” without a country list is unenforceable in practice and invites later disputes about whether a shipment to a neighbouring state breached it. Write the territory as a list of named countries and state explicitly whether “GCC” in the contract means all six member states or only those listed.

  • Saudi Arabia: SFDA notification route, Arabic labelling obligations, local responsible entity.
  • UAE: Dubai Municipality technical guidance and Montaji consumer product registration for Dubai; other emirates and federal requirements verified per project.
  • Other GCC states: verified individually at project start; regional technical references such as GSO cosmetic requirements inform the dossier but do not replace national procedures.

Avoid the phrase “worldwide compliant” entirely. Every statement in the agreement and in the marketing pack should be traceable to a named country and a named document.

Lock the formula version and define change control

Exclusivity over an undefined formula is a promise without an object. The agreement should reference a specific Formula ID and version, and state that the approved specification is the controlling document — including Method IDs and acceptance criteria — and that any modification requires version control and written approval. If development continues after efficacy testing, an impact assessment should be mandatory whenever fragrance, preservative, key actives, or process change. For higher-risk claims, substituting a “close enough” formula for the registered or commercial formula is not acceptable.

Assign registration responsibility explicitly

In the UAE, the local licensed importer, distributor, or registration holder is the responsible party for notification and permits, and for final label approval including Arabic content. The manufacturer’s role is to supply the dossier: formula, fragrance documentation, COA/SDS, free-sale or manufacturing qualification, label file, stability and compatibility reports, and samples. The agreement should separate these obligations clause by clause, because a gap here is the most common cause of a product sitting in a warehouse with no valid registration.

What Packaging Exclusivity Must Define

Exclusivity attaches to the Combination ID, not to “the bottle”

A packaging combination is only usable once it has been validated with your specific formula, filling process, transport conditions, and consumer use. Lock the exclusivity to a unique combination reference that includes the bottle supplier, mould or part number, material, colour and version; the pump or sprayer supplier, model, dose and version; the cap/collar; the gasket and dip tube material, length and version; the decoration specification and approved sample; the Formula ID; the validation record index; and the signed Golden Packaging sample with drawings, photos, and limit samples.

  • An existing mould is not the same as stock on hand.
  • Stock on hand is not the same as validated with your current formula.
  • A bottle that suits an aqueous gel does not automatically suit a high-alcohol, oil, or high-viscosity system.
  • A pump that dispenses water does not necessarily dispense a polymer, silicone, or high-viscosity emulsion reliably over a shelf life.

Separate tooling ownership from decoration ownership

Three distinct assets are usually in play: the mould or tooling, the decoration artwork and plates, and the approved Golden Packaging sample archive. State who owns each, who may use it after termination, whether it can be transferred to another filler, and what the handover cost is. Volume commitments should be tied to the packaging line item separately from the formula line item, so that a shortfall in one does not silently void exclusivity in the other.

Build the climate and transit requirement into the specification

GCC skincare programmes put disproportionate stress on sealing, actuation, decoration durability, and secondary packaging. Heat exposure in transit and storage, humidity, and gift-set configurations all need to be reflected in the validation plan — compatibility, leakage, transport, dispensing function, and high-temperature stability. These are packaging obligations, not formula obligations, and the agreement should say so.

Clauses to Keep Separate in the Brand Agreement

  • Scope of exclusivity: territory (named countries), SKU list, channel (retail, salon, e-commerce), and whether exclusivity is product-level or component-level.
  • Ownership versus licence: who owns the formula, who owns the manufacturing know-how, who owns the tooling, who owns the artwork.
  • Version control: Formula Version, Specification Version, and Combination ID revision rules, with written approval required for any change.
  • Registration support: who files, who holds the registration, which dossier items the manufacturer supplies, and in what format.
  • Validation obligations and cost allocation: compatibility, leakage, transport, dispensing function, high-temperature and stability testing.
  • Claim substantiation: which claims are supported by which protocol, on which sample version, and who re-tests if the formula changes.
  • Volume and term: exclusivity renewal tied to measurable purchase volume, not to verbal assurances of “permanent” exclusivity.
  • Termination and transition: tooling handover, Golden Packaging archive, technical file transfer, and continued supply during transition.

Evidence to Request Before You Sign

Request Evidence that proves it Owner
Definition of the exclusive formula Approved Specification with Formula ID, version, Method IDs, acceptance criteria, and change-control section Manufacturer
Definition of the exclusive pack Combination ID record covering bottle, pump/sprayer, cap, gasket/dip tube, decoration, Formula ID, validation index Manufacturer plus packaging suppliers
Proof the pack works with this formula Compatibility, leakage, transport, dispensing-function and high-temperature test reports linked to the same Combination ID Manufacturer / Lab
Registration-ready dossier Formula, fragrance documentation, COA/SDS, free-sale or manufacturing qualification, label file, stability and micro reports, samples Manufacturer supplies; Buyer or importer files
Claim support for the launch copy Frozen protocol with test ID, formula and packaging versions, endpoints, acceptance criteria, and final report Lab / Manufacturer
Signed physical reference Golden Packaging sample with drawings, specification, photographs and limit-sample archive Manufacturer plus Packaging supplier

How the Split Affects the Launch Timeline

Phase Buyer action Manufacturer action Evidence output
Scope lock Confirm launch country list, SKUs, channel, and claim set Confirm which formula versions and which Combination IDs are being reserved Signed scope annex with country list and IDs
Packaging lock Approve components and decoration direction Issue Combination ID, order tooling and components, issue drawings Combination ID record plus approved artwork
Validation Approve test plan and claim list Run compatibility, leakage, transport, high-temperature and stability work Test reports indexed to the Combination ID and Formula ID
Label and claims review Confirm Arabic/bilingual label content and claim wording with the local registration holder Supply INCI, allergen information, warnings and supporting documents Approved label file and claim substantiation pack
Pilot and handover Approve Golden Packaging and first production batch Run pilot, release batch, hand over dossier Golden Packaging archive, COA, batch record, final technical file

A compressed path is possible when the formula already exists and only decoration is new, or when stock components are validated early against the final formula. What cannot be compressed is the validation step itself, and what cannot be skipped is re-testing after a formula change.

Failure Modes That Surface After Signature

  • Symptom: The product leaks or the pump under-doses after two months in market. Root cause: Components were approved individually rather than as a validated combination with this formula. Prevention: Validate the full combination — seal, dose, dip tube length, viscosity interaction. Evidence to request: Compatibility and leakage reports indexed to the Combination ID.
  • Symptom: Decoration discolours or the label lifts in high heat. Root cause: No high-temperature or humidity exposure in the validation plan. Prevention: Add climate-specific ageing to the packaging test plan. Evidence to request: High-temperature stability and label-adhesion results.
  • Symptom: Registration stalls in one country. Root cause: Dossier built for a different market, or missing documents the importer needs. Prevention: Bind the dossier to named countries at project start. Evidence to request: Country-specific document checklist, COA/SDS, free-sale certificate, label file.
  • Symptom: The exclusive formula quietly changes between pilot and production. Root cause: No version control in the specification. Prevention: Freeze the Formula ID and require written approval for any modification. Evidence to request: Approved Specification with change-control section and batch records.
  • Symptom: A marketing claim cannot be defended. Root cause: The tested sample version does not match the commercial formula. Prevention: Freeze formula, process, and packaging versions before testing; run an impact assessment on any change. Evidence to request: Protocol with test ID and version references, plus the final report.
  • Symptom: Exclusivity is disputed at renewal. Root cause: The clause referred to “our bottle” or “our formula” without identifiers or volume conditions. Prevention: Reference the Formula ID and Combination ID and state the volume threshold. Evidence to request: Contract annex listing IDs, territories and volumes.

Copy-Paste Request List for Your Manufacturer

  • Confirm the launch countries by name and confirm they are listed in the exclusivity annex.
  • Provide the Formula ID and current version for each SKU, with the Approved Specification attached.
  • Confirm in writing whether the formula is developed exclusively for us or adapted from an existing platform.
  • Provide the Combination ID for each SKU, including bottle, pump/sprayer, cap/collar, gasket and dip tube versions.
  • Confirm which components are new tooling, which are existing moulds, and which are stock.
  • State the ownership of tooling, decoration plates and artwork, and the handover process on termination.
  • Attach compatibility, leakage, transport, dispensing-function and high-temperature reports for the combination.
  • Confirm the validation status of each combination against the final formula, not a development formula.
  • Provide stability and micro reports with the storage conditions and test durations stated.
  • Provide COA and SDS for the finished product and for key raw materials.
  • Attach the fragrance documentation and allergen declaration for the market in scope.
  • Provide the proposed label file including INCI, warnings and bilingual content requirements.
  • Confirm which dossier items you supply for registration and which sit with our local importer.
  • State the change-control process for formula, specification and packaging revisions.
  • Provide the claim substantiation protocol with test ID, sample versions and acceptance criteria.
  • Confirm the volume and term conditions attached to formula exclusivity and to packaging exclusivity separately.
  • Approve and sign the Golden Packaging sample and provide the limit-sample archive.
  • Confirm the batch record and release documentation package delivered with each shipment.

FAQ

Can one clause cover both the formula and the packaging?

It can be drafted that way, but it usually fails in practice. The two assets have different owners, different cost drivers, different validation evidence, and different change triggers. Separating them makes it possible to define volume conditions, termination handover, and evidence for each independently.

Does registering in Dubai give us coverage across the GCC?

No. Dubai registration through the applicable systems does not automatically cover the other emirates or other GCC countries. Each target market has its own notification route, labelling requirements, and restricted-ingredient checks, and the local licensed importer or registration holder is normally the responsible party for filing.

If we change only the fragrance, do we need to re-test the packaging?

Fragrance can interact with plastic components, gaskets, and decoration, so a fragrance change should trigger a compatibility review rather than an automatic pass. It also requires an impact assessment on the formula side, because a change to the fragrance is a change to the tested sample.

Is a stock bottle with custom decoration “exclusive packaging”?

Only if the agreement says so and the combination has been reserved. Decoration artwork can be exclusive while the bottle itself remains a catalogue item available to other brands. State clearly which layer — mould, component, decoration, or assembled combination — is exclusive to you.

What single document best protects us during a dispute?

A signed annex listing the Formula ID and version, the Combination ID with all component part numbers, the named territories, the volume conditions, and the Golden Packaging reference. Everything else — the specification, the test reports, the label file — hangs off those identifiers.

Next Step

If you are preparing a GCC skincare launch and need the formula and packaging scopes documented separately before you sign, send your target countries, SKU list and formats, positioning, packaging direction, and timeline. That information is what allows a quotation and a scope annex to be issued without a round of clarification. Request a Quote

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).